Search

Your search keyword '"presenilin-1"' showing total 6,753 results

Search Constraints

Start Over You searched for: Descriptor "presenilin-1" Remove constraint Descriptor: "presenilin-1"
6,753 results on '"presenilin-1"'

Search Results

1. Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.

2. High-intensity interval training combined with cannabidiol supplementation improves cognitive impairment by regulating the expression of apolipoprotein E, presenilin-1, and glutamate proteins in a rat model of amyloid β-induced Alzheimer's disease.

3. Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.

4. Depressive symptoms and hippocampal volume in autosomal dominant Alzheimer's disease.

5. Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice.

6. Quantitative comparison of presenilin protein expression reveals greater activity of PS2‐γ‐secretase.

7. Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.

8. Evolutionary conservation and divergence of the human brain transcriptome

9. IP3R-driven increases in mitochondrial Ca2+ promote neuronal death in NPC disease

10. Assembly of γ-secretase occurs through stable dimers after exit from the endoplasmic reticulum

11. Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease

12. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease.

13. γ-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer's Disease.

14. Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.

15. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.

16. Disease-associated mutations in Niemann-Pick type C1 alter ER calcium signaling and neuronal plasticity

17. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.

18. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.

19. iPSCs-derived nerve-like cells from familial Alzheimer’s disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome

20. Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)

21. Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype

22. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer’s Disease: A Comprehensive Review of the Colombian Kindred

23. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation

24. Mechanisms of hyperexcitability in Alzheimer’s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls

25. Presenilin-1 F105C mutation leads to tau accumulation in human neurons via the Akt/mTORC1 signaling pathway

26. The transcriptomic landscape of neurons carrying PSEN1 mutations reveals changes in extracellular matrix components and non-coding gene expression

27. Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-β Load and Cognitive Impairment in Alzheimer's Disease.

29. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.

30. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease

31. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

32. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept

33. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease

34. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy

35. Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene.

36. Early⁃onset Alzheimer's disease caused by PSEN1 gene mutation: two cases reports and literature review

37. Presenilin-1 F105C mutation leads to tau accumulation in human neurons via the Akt/mTORC1 signaling pathway.

38. Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease.

39. Análisis in silico a nivel proteico de la estructura de presenilina-1 en homínidos.

40. Data from Boston University Advance Knowledge in Alzheimer Disease (Cognitive Outcomes In Autosomal-dominant Alzheimer's Disease: a Comprehensive Review From a Colombian Kindred With the Presenilin-1 E280a Mutation).

41. Differential expression and modulation of presenilin-1 and presenilin-2 in neural cell lines.

42. Data on Alzheimer Disease Reported by Researchers at Department of Neurology (Young-onset Alzheimer Dementia Due To a Novel Pathogenic presenilin 1 Variant Initially Misdiagnosed As Autoimmune Encephalitis).

43. Association between PSEN1 p.E318G Variant and APOE Polymorphism and Alzheimer Disease in Turkish Patients

44. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease

45. Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1

46. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation

47. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer’s disease

48. The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule

49. A Metal-Free Method for Producing MRI Contrast at Amyloid-β

50. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease

Catalog

Books, media, physical & digital resources